Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placebo
Crossref DOI link: https://doi.org/10.1186/s12944-016-0197-4
Published Online: 2016-02-13
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Toth, Peter P.
Hamon, Sara C.
Jones, Steven R.
Martin, Seth S.
Joshi, Parag H.
Kulkarni, Krishnaji R.
Banerjee, Poulabi
Hanotin, Corinne
Roth, Eli M.
McKenney, James M.
Funding for this research was provided by:
Sanofi and Regeneron Pharmaceuticals, Inc.